Novartis plans to publish hydroxychloroquine data this month

News about our members

April 13th 2020Members news

The company wants to conduct trials in Spain with ruloxitinib and canakinumab. Jesus Ponce (Novartis) and Joaquín Rodrigo (Sandoz) explain the actions of the multinational in Spain and in the world against Covid-19.

READ MORE

recently published

Post thumb
Informative breakfasts "Study on the market of biosimilar medicines in the National Health System in Spain"
March 18 2024
Post thumb
Horizon scanning
Jan 31 2024
Post thumb
Early Treatment: the role of biosimilars
18 2023 December
Post thumb
Study on the market for biosimilar medicines in the National Health System in Spain 2016-2022
18 2023 December

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE